Fibrinogen is the soluble protein that becomes the mesh of every blood clot. As an acute phase reactant it rises with inflammation, and elevated levels independently predict heart attack and stroke.
Standard range versus optimal range
| Framework | Fibrinogen value | Source |
|---|---|---|
| Typical adults | about 200-400 mg/dL | Common laboratory range |
| Cardiovascular risk gradient | roughly 1.8x risk per 1 g/L increase | Fibrinogen Studies Collaboration, JAMA 2005 |
| High | above 400-450 mg/dL | Common laboratory range |
When it runs high
High fibrinogen thickens blood and feeds clot formation, rising with smoking, inflammation, infection, obesity and pregnancy. A landmark individual-participant meta-analysis linked each 1 g/L rise to a near doubling of vascular event risk.
- Smoking, one of the strongest drivers
- Infection and chronic inflammation
- Obesity and metabolic syndrome
- Pregnancy, physiological
- Estrogen therapy
- Nephrotic syndrome
When it runs low
Low fibrinogen impairs clotting and matters mainly in bleeding emergencies, liver failure and rare inherited deficiencies. Mildly low values without bleeding are usually insignificant.
- Liver failure reducing production
- Disseminated intravascular coagulation consuming it
- Inherited afibrinogenemia, rare
- Massive blood loss and transfusion dilution
The clotting protein that predicts disease
Fibrinogen does double duty, it is the raw material of clots and an acute phase reactant that rises whenever the immune system is active. That combination makes it a bridge between inflammation and thrombosis, the two processes that conspire in every heart attack. The Fibrinogen Studies Collaboration pooled 31 prospective studies and over 154,000 people, finding moderately strong associations between fibrinogen and coronary disease, stroke and even nonvascular mortality.
Smoking’s chemical fingerprint
Few habits raise fibrinogen as reliably as cigarettes, and quitting lowers it within weeks, one of the fastest measurable rewards of stopping. This partly explains smoking’s clot-promoting effect, blood that is literally thicker and quicker to gel. Estrogen therapy and pregnancy raise it too, which is why values must always be read against sex, smoking status and medication list.
Where it fits clinically
Fibrinogen never became a routine screening target like cholesterol, partly because no drug selectively lowers it. Its everyday home is different, monitoring bleeding risk in surgery and obstetrics, tracking inflammatory diseases, and adding context to cardiovascular risk alongside hs-CRP. For personal tracking, the actionable lesson remains indirect but powerful, the levers that lower fibrinogen, quitting smoking, losing visceral fat, calming inflammation, are the ones that protect arteries by every other measure too.
Related calculators
Related biomarkers hs-CRP · IL-6 · Platelets